Oxycodone Hydrochloride Hameln Pharma (Oxycodone Hydrochloride)

Oxycodone Hydrochloride is an opioid analgesic that acts on the central nervous system to relieve pain.

• Acute postoperative pain: provides strong analgesia during the immediate recovery period.
• Cancer‑related pain: helps control persistent pain associated with malignant disease.
• Severe chronic non‑cancer pain: offers long‑lasting relief when other opioids are ineffective.
• Traumatic injury pain: reduces pain intensity after major injuries such as fractures.
• Palliative care pain: improves comfort for patients with life‑limiting illnesses.

• Oxycodone Hydrochloride binds primarily to μ‑opioid receptors in the brain and spinal cord, activating inhibitory G‑protein pathways that decrease neuronal excitability and reduce the transmission of nociceptive signals. This receptor activation also modulates dopamine release, contributing to its analgesic effect while producing typical opioid‑related central nervous system effects.

Oxycodone Hydrochloride may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Constipation: reduced gastrointestinal motility leading to hard stools.
• Nausea: feeling of queasiness, often accompanied by vomiting.
• Drowsiness: increased sleepiness or fatigue.
• Dizziness: sensation of light‑headedness or unsteadiness.
• Dry mouth: reduced salivary flow causing oral discomfort.
• Pruritus: mild itching, often localized.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be life‑threatening.
• Severe hypotension: marked drop in blood pressure causing faintness.
• Opioid use disorder: dependence or addiction with misuse potential.
• Seizures: rare occurrence of convulsive episodes.
• Anaphylaxis: acute allergic reaction with airway compromise.
• adrenal insufficiency: rare hormonal imbalance affecting stress response.

When prescribing Oxycodone Hydrochloride, clinicians should assess patient risk factors and monitor for adverse events.

• Assess respiratory function: monitor breathing rate and oxygen saturation, especially after dose initiation.
• Evaluate hepatic and renal function: adjust use in patients with significant impairment.
• Review concomitant CNS depressants: avoid additive sedation or respiratory depression.
• Counsel on constipation management: use laxatives or stool softeners proactively.
• Educate on dependence risk: discuss safe use, storage, and disposal.
• Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Oxycodone Hydrochloride interacts with several drug classes; careful review of a patient’s medication list is essential.

Major Interactions (Avoid)

• Benzodiazepines: combined use can cause profound respiratory depression and sedation.
• Central nervous system depressants: alcohol, barbiturates, or other opioids increase risk of fatal overdose.
• CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise oxycodone plasma levels, heightening toxicity.

Moderate Interactions (Monitor Closely)

• CYP2D6 inhibitors (e.g., fluoxetine, quinidine): may reduce conversion to active metabolites, altering analgesic effect.
• Anticholinergic agents: may exacerbate constipation and urinary retention.
• Diuretics: can increase risk of orthostatic hypotension when combined with opioid‑induced vasodilation.